Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

NSE : NGLFINEBSE : 524774ISIN CODE : INE887E01022Industry : Pharmaceuticals & DrugsHouse : Private

BSE2349.0014.2 (+0.61 %)

PREV CLOSE ( ) 2334.80

OPEN PRICE ( ) 2335.00

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 366

TODAY'S LOW / HIGH ( )2334.25 2449.90

52 WK LOW / HIGH ( )1428.2 2822.5

NSE2327.40-13.4 (-0.57 %)

PREV CLOSE( ) 2340.80

OPEN PRICE ( ) 2364.20

BID PRICE (QTY) 2327.40 (11)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 5999

TODAY'S LOW / HIGH( ) 2306.15 2452.10

52 WK LOW / HIGH ( )1426.75 2823.9

Managing Director	Rahul J Nachane
Company Secretary	Pallavi Pednekar
Non Executive Director	Ajita Nachane
Additional Director	Dhananjay Mungale
Non Executive Independent Director	Jayaram Sitaram Sarala Menon
Whole Time Director	Rajesh N Lawande

Incorporation Year : 1981

Registered Office :

Address : 301 E Square,Subhash Road,Vile Parle (East) Mumbai,
Maharashtra-400057 .

Phone : 022 26636450

Industry : Pharmaceuticals & Drugs

Listing : BSE,NSE